Drug intelligence / Profile preview

iDNA-based Venezuelan equine encephalitis vaccine

Development stage
Unknown
Lead developer
Medigen Biotechnology
Modality
DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Intramuscular, Intradermal, Transdermal
01

Overview

The iDNA-based Venezuelan equine encephalitis vaccine is a novel vaccine technology that combines advantages of both DNA and live attenuated vaccines. It uses an infectious DNA platform (iDNA) that encodes the full genome of a live-attenuated Venezuelan equine encephalitis virus (VEEV) vaccine strain. When administered, the iDNA launches replication of the attenuated virus in vivo, inducing protective immune responses against VEEV. This approach requires lower doses than conventional DNA vaccines and eliminates the need for cold-chain storage of live virus vaccines. The technology has shown promising results in animal models, with successful seroconversion and protection against lethal VEEV challenge.

Beyond the preview

Go deeper on iDNA-based Venezuelan equine encephalitis vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iDNA-based Venezuelan equine encephalitis vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call